Sarepta Therapeutics Inc (NASDAQ:SRPT)

25.40
BATS BZX Real-Time Price
As of 2:39pm ET
 -0.74 / -2.83%
Today’s Change
11.33
Today|||52-Week Range
35.41
+75.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-4000
Investor Relations:
(617) 274-4052

Employees

Shareholders

Mutual fund holders34.07%
Other institutional26.74%
Individual stakeholders0.77%

Top Executives

Edward M. KayeSenior VP, Chief Executive & Medical Officer
Sandesh MahatmeSenior VP, Chief Financial & Accounting Officer
Patrick L. IversenSenior Vice President-Research & Innovation
David Tyronne HowtonSecretary, Senior Vice President & General Counsel
Jayant AphaleSenior Vice President-Technical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account